Beneficial effects of r-h-CLU on disease severity in different animal models of peripheral neuropathies

G. Dati, A. Quattrini, L. Bernasconi, M. C. Malaguti, B. Antonsson, F. Nicoletti, C. Alliod, R. Di Marco, Y. Sagot, P. A. Vitte, A. Hiver, B. Greco, A. Roach, P. F. Zaratin

Research output: Contribution to journalArticlepeer-review


Clusterin is a protein involved in multiple biological events, including neuronal cytoprotection, membrane recycling and regulation of complement-mediated membrane attack after injury. We investigated the effect of recombinant human clusterin in preclinical models of peripheral neuropathies. Daily treatment with clusterin accelerated the recovery of nerve motor evoked potential parameters after sciatic nerve injury. Prophylactic or therapeutic treatment of experimental autoimmune neuritis rats with clusterin also accelerated the rate of recovery from the disease, associated with remyelination of demyelinated nerve fibers. These data demonstrate that clusterin is capable of ameliorating clinical, neurophysiological and pathological signs in models of peripheral neuropathies.

Original languageEnglish
Pages (from-to)8-17
Number of pages10
JournalJournal of Neuroimmunology
Issue number1-2
Publication statusPublished - Oct 2007


  • Experimental autoimmune neuritis (EAN)
  • Peripheral neuropathies
  • Recombinant-human clusterin (r-h-CLU)
  • Sciatic nerve crush

ASJC Scopus subject areas

  • Immunology
  • Clinical Neurology
  • Immunology and Allergy
  • Neurology


Dive into the research topics of 'Beneficial effects of r-h-CLU on disease severity in different animal models of peripheral neuropathies'. Together they form a unique fingerprint.

Cite this